These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31866582)

  • 1. Overexpressed methyltransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR-149-3p/S100A4/p53 axis.
    Liu Y; Yang C; Zhao Y; Chi Q; Wang Z; Sun B
    Aging (Albany NY); 2019 Dec; 11(24):12328-12344. PubMed ID: 31866582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
    Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
    Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
    Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
    Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells.
    Song J; Li Y
    Cancer Sci; 2017 Jan; 108(1):23-31. PubMed ID: 27743413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-3189-3p Mimics Enhance the Effects of S100A4 siRNA on the Inhibition of Proliferation and Migration of Gastric Cancer Cells by Targeting CFL2.
    Bian Y; Guo J; Qiao L; Sun X
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342841
    [No Abstract]   [Full Text] [Related]  

  • 8. p53 induces miR-199a-3p to suppress mechanistic target of rapamycin activation in cisplatin-induced acute kidney injury.
    Yang A; Liu F; Guan B; Luo Z; Lin J; Fang W; Liu L; Zuo W
    J Cell Biochem; 2019 Oct; 120(10):17625-17634. PubMed ID: 31148231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
    Li B; Wang W; Li Z; Chen Z; Zhi X; Xu J; Li Q; Wang L; Huang X; Wang L; Wei S; Sun G; Zhang X; He Z; Zhang L; Zhang D; Xu H; El-Rifai W; Xu Z
    Cancer Lett; 2017 Dec; 410():212-227. PubMed ID: 28965855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
    Tan S; Shi H; Ba M; Lin S; Tang H; Zeng X; Zhang X
    Int J Mol Med; 2016 Apr; 37(4):1030-8. PubMed ID: 26935807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM).
    Fan X; Zhou S; Zheng M; Deng X; Yi Y; Huang T
    Biomed Pharmacother; 2017 Apr; 88():507-514. PubMed ID: 28126676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
    Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
    Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-194-3p represses the docetaxel resistance in colon cancer by targeting KLK10.
    Zhao J; Wang Y; Wang Y; Gao J; Wu X; Li H
    Pathol Res Pract; 2022 Aug; 236():153962. PubMed ID: 35691099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression.
    Mudduluru G; Ilm K; Fuchs S; Stein U
    Oncotarget; 2017 Mar; 8(13):21081-21094. PubMed ID: 28423501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
    Phatak P; Byrnes KA; Mansour D; Liu L; Cao S; Li R; Rao JN; Turner DJ; Wang JY; Donahue JM
    Oncogene; 2016 Apr; 35(16):2087-97. PubMed ID: 26234674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
    Cheng FH; Zhao ZS; Liu WD
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21
    Xu S; Huang H; Chen YN; Deng YT; Zhang B; Xiong XD; Yuan Y; Zhu Y; Huang H; Xie L; Liu X
    Cell Cycle; 2016 Nov; 15(21):2920-2930. PubMed ID: 27559850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines.
    Port M; Glaesener S; Ruf C; Riecke A; Bokemeyer C; Meineke V; Honecker F; Abend M
    Mol Cancer; 2011 May; 10():52. PubMed ID: 21575166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
    Wang M; Zhang R; Zhang S; Xu R; Yang Q
    Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.
    Huang Y; Chuang AY; Ratovitski EA
    Cell Cycle; 2011 Nov; 10(22):3938-47. PubMed ID: 22071691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.